Pages

Wednesday, April 23, 2014

Spectrum Pharmaceuticals' Pivotal Trial of...

CE Melphalan is being developed as a novel version of the well-established conditioning treatment in autologous transplant for patients with multiple myeloma.

http://ift.tt/1hiuoPE

No comments:

Post a Comment